Atea Pharmaceuticals Inc (AVIR)
R&D Expense Growth
-31.57%
Quarterly · Period ending:
AVIR R&D Expense Growth
Latest reported-31.57%period ending
Latest reported-31.57%period ending
AVIR Quarterly R&D Growth (QoQ) (0.00% → -31.57%)
Latest values, visible window
High-resolution chart · PNG
AVIR r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -31.5651% | |
| -13.978% | |
| 24.6982% | |
| 18.8133% | |
| 9.0961% | |
| 15.2429% | |
| -1.8655% | |
| -24.6051% | |
| -39.7377% | |
| 64.2888% | |
| 9.7592% | |
| 6.6433% | |
| -0.0467% | |
| 4.588% | |
| 483.894% | |
| -75.2996% | |
| -34.8448% | |
| -47.2799% | |
| 34.3848% | |
| 8.0798% | |
| 49.7987% | |
| 91.9038% | |
| 1.8013% | |
| 75.3836% | |
| 174.9025% | |
| -19.1459% | |
| 44.7117% | |
| -14.6851% | |
| 95.7064% | |
| 0% |